Katy Rezvani, M.D., Ph.D
@lab_rezvani
PI of the Rezvani lab. Researching NK cells' role in mediating protection against cancer and strategies to enhance their killing function. Views are my own.
ID:1223726418284118017
https://www.mdanderson.org/research/departments-labs-institutes/labs/rezvani-laboratory.html 01-02-2020 21:55:10
235 Tweets
4,0K Followers
518 Following
Congratulations to Carl June, MD, Center Director for the PICI Center at Penn Medicine, and Michel Sadelain, MD, PhD, from Memorial Sloan Kettering Cancer Center!
Congratulations to Michel Sadelain, MD, PhD, FAACR, of Memorial Sloan Kettering Cancer Center, awarded the Gairdner Foundation International Awards today for his work on CD19-CAR T cell therapy for cancer, along with Zelig Eshhar, PhD, Weizmann Institute. #AACRFellows
Deeply grateful to the SU2C MEG VOSBURG T-CELL LYMPHOMA DREAM TEAM for supporting our CAR NK program to target CD5. And thrilled to share FDA clearance for a clinical trial targeting CD5 CAR NK cells in patients with T cell lymphoma. Stand Up To Cancer MD Anderson Cancer Center Center for Cell and Gene Therapy
🚨Just published: The registration enabling clinical data set for an affinity-enhanced TCR targeting the cancer-germline antigen MAGE-4. Afami cell on track to be the *first* FDA approved TCR gene therapy and first gene therapy product for a solid cancer.
thelancet.com/journals/lance…
Secure your spot at Frontiers in Cancer Immunotherapy 2024 presented with The Tisch Cancer Institute, supported by Pfizer Inc.. Ft keynote speakers Carl June (@Penn), Miriam Merad, MD, PhD (@IcahnMountSinai), dana_peer (@MSKCancerCenter) & Katy Rezvani, M.D., Ph.D (@MDAndersonNews). Register: bit.nyas.org/3smWAyr
Fantastic talk by Dr Hind Rafei on current status of NK cell therapy - Nitin Jain
Hind Rafei Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center BMDACC Stem Cell Program
#Cancer #Cancer Centre #NKCells #OncoDaily #Oncology #SolidTumors #Tumors
oncodaily.com/41853.html
Congratulations Hind Rafei !! An outstanding presentation by a superstar member of our team! So excited about your project to enhance the potency of NK cells against solid tumors, and looking forward to translating your work to the clinic. MD Anderson Cancer Center BMDACC Stem Cell Program
Congratulations Rafet for an outstanding presentation! So proud of all that you’re achieving, and looking forward to what the future holds for NK Cell Therapy #ESHCLL2024 MD Anderson Cancer Center
Important study showing the promise of locoregional delivery of CAR T cells in glioblastoma. Congratulations to Christine Brown and co-authors City of Hope Nature Medicine
NEW Magnum Opus to date for CAR T cells in solid tumors - Product fitness, local delivery & pre-existing T cells in tumor impact responses. Congrats to Christine Brown City of Hope team Nature Medicine #immunotherapy #CARTCell #tcellrx nature.com/articles/s4159…
The MD Anderson Cancer Center 2024 HSC MDS symposium organized by Simona Colla begins tmrw.
We’re excited to welcome speakers & attendees to #Houston tonight
Superb speaker lineup & excellent topics on hematopoiesis & #MDSsm
Official meeting hashtag: #HSCMDS24
G Garcia-Manero Halene Lab…
Fantastic meeting on Cell Therapy in Paris, May 2024!
Justin Eyquem Belkaid Lab @realFlorentGinhoux Katy Rezvani, M.D., Ph.D Marson Lab Majzner_Lab Julie Helft Alena Gros @amigorena Roychoudhuri Lab Luca Gattinoni Claire Roddie Suman MITRA Laurie Menger @CecileAlanio @MichelSadelain
Many congratulations to Carin Hagberg, MD for being a 2024 honoree of the Texas Women’s Hall of Fame GHWCC. Extremely well deserved. TSAPhysicians MD Anderson Cancer Center
🚨Pre-print alert: Here, we show that CAR-T *and* CAR-NK persistence is negatively self-regulated through activation dependent FAS ligand expression. Further highlights FAS as an actionable molecule to enhance cell therapies. Parker Institute for Cancer Immunotherapy Memorial Sloan Kettering Cancer Center
biorxiv.org/content/10.110…
